THERIVA BIOLOGICS INC (TOVX) Total Assets by Year
THERIVA BIOLOGICS INC closed fiscal year 2025 with $38.2M in total assets, $22.9M in total liabilities and $15.4M in shareholder equity. This represents an increase of 8.2% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters THERIVA BIOLOGICS INC has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
TOVX Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY25DEF 14A | FY24DEF 14A | FY23DEF 14A | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $38.2M+8.2% | $35.4M-36.0% | $55.2M-23.2% | $71.9M+2.1% | $70.4M+736.7% | $8.4M-51.2% | $17.2M-42.8% | $30.1M+60.0% | $18.8M-16.3% | $22.5M-27.1% | $30.8M+61.1% | $19.1M+17.8% | $16.3M+21.1% | $13.4M+79.5% | $7.5M |
| Total Liabilities | $22.9M+40.4% | $16.3M+4.9% | $15.5M-10.3% | $17.3M+248.9% | $5.0M-62.4% | $13.2M-14.5% | $15.4M+17.9% | $13.1M-35.7% | $20.3M+0.4% | $20.2M+27.8% | $15.8M+65.2% | $9.6M+833.6% | $1.0M+160.0% | $395K-5.3% | $417K |
| Total Equity | $15.4M-19.3% | $19.1M-48.4% | $37.0M-28.7% | $51.8M-20.8% | $65.4M+1472.1% | -$4.8M-361.8% | $1.8M-89.3% | $17.1M+1240.9% | -$1.5M-138.9% | $3.8M-76.0% | $16.1M+68.0% | $9.6M-37.3% | $15.2M+16.9% | $13.0M+84.6% | $7.1M |
TOVX Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $34.9M-2.7% | $38.2M+18.9% | $38.2M+8.2% | $30.8M-23.1% | $35.8M-15.5% | $32.2M-34.0% | $35.4M-36.0% | $40.1M-34.8% | $42.4M-35.2% | $48.7M-28.2% | $55.2M-23.2% | $61.5M-20.2% |
| Total Liabilities | $22.7M-10.1% | $22.8M+37.1% | $22.9M+40.4% | $24.1M+55.7% | $25.2M+71.0% | $16.7M+14.1% | $16.3M+4.9% | $15.5M-12.4% | $14.7M-16.7% | $14.6M-15.6% | $15.5M-10.3% | $17.7M-1.8% |
| Total Equity | $12.2M+14.7% | $15.4M-0.6% | $15.4M-19.3% | $6.7M-72.6% | $10.6M-59.0% | $15.5M-50.6% | $19.1M-48.4% | $24.6M-40.1% | $25.9M-42.5% | $31.4M-34.4% | $37.0M-28.7% | $41.1M-27.0% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More THERIVA BIOLOGICS INC financials
Frequently Asked Questions
What was THERIVA BIOLOGICS INC's total assets in fiscal year 2025?
THERIVA BIOLOGICS INC closed fiscal year 2025 with $38.2M in total assets, $22.9M in total liabilities and $15.4M in shareholder equity.
How fast is THERIVA BIOLOGICS INC's total assets growing?
THERIVA BIOLOGICS INC (TOVX) total assets rose by 8.2% year over year, from $35.4M to $38.2M in fiscal year 2025.
How has THERIVA BIOLOGICS INC's total assets changed over the years?
Across the 15 fiscal years this page covers, THERIVA BIOLOGICS INC (TOVX) total assets went from $7.5M in fiscal year 2011 to $38.2M in fiscal year 2025.
What was THERIVA BIOLOGICS INC's total assets in the most recent quarter?
THERIVA BIOLOGICS INC (TOVX) reported $34.9M in total assets in Q2 2026. This represents a decrease of 2.7% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what THERIVA BIOLOGICS INC (TOVX) reported on that line in every period on record.